Michael Cohen, Adam Schoen, and Sam Williams Speak at Venture Financing Event Hosted by the Rosenman Institute
PUBLISHED ON: 02/11/2021
BOSTON – February 11, 2021 – Michael Cohen led a speaker panel also featuring Adam Schoen and Sam Williams at the University of California, San Francisco Rosenman Institute’s event “Venture Financing: Soup to Nuts” on February 9. Michael, Adam, and Sam are Brown Rudnick partners in the Corporate and Life Sciences Practice Groups.
The event audience included more than 150 participants in the life sciences industry, including dealmakers from medical technology and digital health companies.
Michael, Adam, and Sam discussed the importance of understanding the venture financing process, where there is room to negotiate, and which investor rights are non-negotiable. Their talk also covered the process of a typical venture investment, including real-life examples and the consequences of certain decisions in the lead-up to closing. In his practice, Michael represents early stage and mid-market companies and venture, hedge, and private equity funds in connection with mergers and acquisitions, joint ventures and strategic alliances, financing transactions, and general corporate and commercial matters at all stages of the corporate life cycle. Michael works closely with Brown Rudnick’s London office in counseling U.K. and European clients engaging in transactions involving U.S. concerns.
Adam has been in the life sciences industry for over twenty years and has fifteen years of experience advising life sciences and medical device funds, companies, and academic institutions. Adam helps his clients build, grow, invest in, buy, and sell companies of all sizes all over the world. Adam’s practice is multidisciplinary, encompassing all aspects of patent preparation and prosecution, portfolio development, product clearance, freedom to operate analysis, intellectual property due diligence, licensing, and other agreement work.
Sam has nearly three decades of experience and concentrates his practice on mergers and acquisitions, corporate finance, venture capital, licensing and strategic partnerships and international law. He counsels publicly and privately held corporations in a variety of industries including businesses in the financial services, information technology, semiconductor, communications and other high technology sectors, and life sciences.
The UCSF Rosenman Institute, a QB3 health technology initiative at the University of California, San Francisco, is a community of investors, clinicians, and technology entrepreneurs who create solutions for unmet clinical needs. Its mission is to drive innovation and education and improve patient care by helping entrepreneurs from concept to commercialization.
About Brown Rudnick LLP
Brown Rudnick combines ingenuity with experience to achieve great outcomes for our clients. We deliver partner-driven services, incentivize our lawyers to collaborate in the client’s best interest, and put excellence before scale. We focus on practices such as distressed debt, corporate restructuring, M&A, white collar defense, international disputes and intellectual property, where we are a recognized leader. We have more than 250 lawyers and government relations professionals across the United States and Europe, with offices in key financial centers. Beyond the United States and Europe, we serve clients in the Middle East, North Africa, the Caribbean, and Latin America.
+1 (212) 209-4870